Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents

References

• AllémannEGurnyRDoelkerEDrug-loaded nanoparticles – preparation methods and drug targeting issuesEur J Pharm Biopharm199339173191
   Web of Science ®Google Scholar
• MuthuMSSinghSTargeted nanomedicines: Effective treatment modalities for cancer, AIDS and brain disordersNanomedicine20094110511819093899
   PubMed Web of Science ®Google Scholar
• LangerRDrug delivery and targetingNature199839266795109579855
   PubMed Web of Science ®Google Scholar
• DavisMEChenZShinDMNanoparticle therapeutics: An emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• LammersTHenninkWStormGTumour-targeted nanomedicines: Principles and practiceBr J Cancer200899339239718648371
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotech2007212751760
   PubMed Web of Science ®Google Scholar
• LangerRFolkmanJPolymers for the sustained release of proteins and other macromoleculesNature19762635580797800995197
   PubMed Web of Science ®Google Scholar
• DuncanRPolymer conjugates as anticancer nanomedicinesNat Rev Cancer20066968870116900224
   PubMed Web of Science ®Google Scholar
• LammersTSubrVUlbrichKHenninkWEStormGKiesslingFPolymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapyNano Today20105197212
   Web of Science ®Google Scholar
• GrundSPolymers in drug delivery – state of the art and future trendsAdv Eng Mater2011 In press
   Google Scholar
• GrefRLückMQuellecPStealth’corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces2000183–430131310915952
   PubMed Web of Science ®Google Scholar
• PeracchiaMHarnischSPinto-AlphandaryHVisualization of in vitro protein-rejecting properties of PEGylated Stealth® polycyano-acrylate nanoparticlesBiomaterials199920141269127510403044
   PubMed Web of Science ®Google Scholar
• AthanasiouKANiederauerGGAgrawalCSterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymersBiomaterials1996172931028624401
   PubMed Web of Science ®Google Scholar
• StevanovicMUskokovicDPoly(lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitaminsCurr Nanosci200951114
   Web of Science ®Google Scholar
• JainRThe manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devicesBiomaterials200021232475249011055295
   PubMed Web of Science ®Google Scholar
• LoweCEPreparation of high molecular weight poly hydroxyacetic ester US Patent 26681621954
   Google Scholar
• GildingDReedABiodegradable polymers for use in surgery – polyglycolic/poly (actic acid) homo-and copolymers: 1Polymer1979201214591464
   Web of Science ®Google Scholar
• BalaIHariharanSRaviKPLGA nanoparticles in drug delivery: The state of the artCrit Rev Ther Drug Carrier Syst200421538742215719481
   PubMed Web of Science ®Google Scholar
• LiSMcCarthySInfluence of crystallinity and stereochemistry on the enzymatic degradation of poly (lactide)sMacromolecules1999321344544456
   Web of Science ®Google Scholar
• ParkTDegradation of poly (D, L-lactic acid) microspheres: Effect of molecular weightJ Control Release1994302161173
   Web of Science ®Google Scholar
• SchlieckerGSchmidtCFuchsSKisselTCharacterization of a homologous series of D, L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitroBiomaterials200324213835384412818556
   PubMed Web of Science ®Google Scholar
• PanyamJDaliMMSahooSKPolymer degradation and in vitro release of a model protein from poly (D, L-lactide-co-glycolide) nano-and microparticlesJ Control Release2003921–217318714499195
   PubMed Web of Science ®Google Scholar
• BarrattGMTherapeutic applications of colloidal drug carriersPharm Sci Technolo Today20003516317110785658
   PubMedGoogle Scholar
• PanyamJZhouW-ZPrabhaSSahooSKLabhasetwarVRapid endolysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene deliveryFASEB J200216101217122612153989
   PubMed Web of Science ®Google Scholar
• VauthierCBouchemalKMethods for the preparation and manufacture of polymeric nanoparticlesPharm Res20092651025105819107579
   PubMed Web of Science ®Google Scholar
• AntonNBenoitJPSaulnierPDesign and production of nanoparticles formulated from nano-emulsion templates – a reviewJ Control Release2008128318519918374443
   PubMed Web of Science ®Google Scholar
• AsteteCSabliovCSynthesis and characterization of PLGA nanoparticlesJ Biomater Sci Polym Ed200617324728916689015
   PubMed Web of Science ®Google Scholar
• MuLFengSA novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGSJ Control Release2003861334812490371
   PubMed Web of Science ®Google Scholar
• ChavanpatilMDPatilYPanyamJSusceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug effluxInt J Pharm20063201–215015616713148
   PubMed Web of Science ®Google Scholar
• FengSSNanoparticles of biodegradable polymers for new-concept chemotherapyExpert Rev Med Devices20041111512516293015
   PubMed Web of Science ®Google Scholar
• LamprechtAUbrichNHombreiro PerezMLehrCMHoffmanMMaincentPInfluences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization techniqueInt J Pharm2000196217718210699713
   PubMed Web of Science ®Google Scholar
• TakeuchiHYamamotoHKawashimaYMucoadhesive nanoparticulate systems for peptide drug deliveryAdv Drug Deliv Rev2001471395411251244
   PubMed Web of Science ®Google Scholar
• Moinard-ChécotDChevalierYBriançonSFessiHGuinebretièreSNanoparticles for drug delivery: Review of the formulation and process difficulties illustrated by the emulsion-diffusion processJ Nanosci Nanotechnol200691026642681
   Web of Science ®Google Scholar
• MurakamiHKobayashiMTakeuchiHKawashimaYPreparation of poly (D, L-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion methodInt J Pharm1999187214315210502620
   PubMed Web of Science ®Google Scholar
• KwonHYLeeJYChoiSWJangYKimJHPreparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method*1Colloids Surf A PhysicochemEng Asp20011821–3123130
   Web of Science ®Google Scholar
• YooHSLeeKHOhJEParkTGIn vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugatesJ Control Release200068341943110974396
   PubMed Web of Science ®Google Scholar
• KonanYCernyRFavetJBertonMGurnyRAllémannEPreparation and characterization of sterile sub-200 nm meso-tetra (4-hydroxylphenyl) porphyrin-loaded nanoparticles for photodynamic therapyEur J Pharm Biopharm200355111512412551712
   PubMed Web of Science ®Google Scholar
• IbrahimHBindschaedlerCDoelkerEBuriPGurnyRAqueous nanodispersions prepared by a salting-out processInt J Pharm1992871–3239246
   Web of Science ®Google Scholar
• KonanYNGurnyRAllémannEPreparation and characterization of sterile and freeze-dried sub-200 nm nanoparticlesInt J Pharm20022331–223925211897428
   PubMed Web of Science ®Google Scholar
• FessiHPuisieuxFDevissaguetJPAmmouryNBenitaSNanocapsule formation by interfacial polymer deposition following solvent displacementInt J Pharm1989551R1R4
   Web of Science ®Google Scholar
• GovenderTStolnikSGarnettMIllumLDavisSPLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drugJ Control Release19995721711859971898
   PubMed Web of Science ®Google Scholar
• BetancourtTBrownBBrannon-PeppasLDoxorubicin-loaded PLGA nanoparticles by nanoprecipitation: Preparation, characterization and in vitro evaluationNanomedicine20072221923217716122
   PubMed Web of Science ®Google Scholar
• ThiouneOFessiHDevissaguetJPuisieuxFPreparation of pseudolatex by nanoprecipitation: Influence of the solvent nature on intrinsic viscosity and interaction constantInt J Pharm19971462233238
   Web of Science ®Google Scholar
• GaumetMVargasAGurnyRDelieFNanoparticles for drug delivery: The need for precision in reporting particle size parametersEur J Pharm Biopharm20086911917826969
   PubMed Web of Science ®Google Scholar
• DunneMCorriganORamtoolaZInfluence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particlesBiomaterials200021161659166810905407
   PubMed Web of Science ®Google Scholar
• MittalGSahanaDBhardwajVRavi KumarMEstradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivoJ Control Release20071191778517349712
   PubMed Web of Science ®Google Scholar
• SoppimathKAminabhaviTKulkarniARudzinskiWBiodegradable polymeric nanoparticles as drug delivery devicesJ Control Release2001701–212011166403
   PubMed Web of Science ®Google Scholar
• ChengFWangSSuCStabilizer-free poly (lactide-co-glycolide) nanoparticles for multimodal biomedical probesBiomaterials200829132104211218276001
   PubMed Web of Science ®Google Scholar
• FonsecaCSimoesSGasparRPaclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activityJ Control Release200283227328612363453
   PubMed Web of Science ®Google Scholar
• EsmaeiliFGhahremaniMOstadSFolate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG–folate conjugateJ Drug Target200816541542318569286
   PubMed Web of Science ®Google Scholar
• Ricci-JuniorEMarchettiJZinc (II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy useInt J Pharm20063101–218719516442755
   PubMed Web of Science ®Google Scholar
• MoYLimLYPreparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristateJ Control Release20051071304216051391
   PubMed Web of Science ®Google Scholar
• PanyamJSahooSPrabhaSBargarTLabhasetwarVFluorescence and electron microscopy probes for cellular and tissue uptake of poly (D, L-lactide-co-glycolide) nanoparticlesInt J Pharm20032621–211112927382
   PubMed Web of Science ®Google Scholar
• YangAYangLLiuWLiZXuHYangXTumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: Preparation and in vitro evaluationInt J Pharm2007331112313217097246
   PubMed Web of Science ®Google Scholar
• DongYFengSPoly (D, L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugsBiomaterials200526306068607615894372
   PubMed Web of Science ®Google Scholar
• Ravi KumarMBakowskyULehrCPreparation and characterization of cationic PLGA nanospheres as DNA carriersBiomaterials200425101771177714738840
   PubMed Web of Science ®Google Scholar
• SongKLeeHChoungIChoKAhnYChoiEThe effect of type of organic phase solvents on the particle size of poly (D, L-lactide-co-glycolide) nanoparticlesColloids Surf A PhysicochemEng Asp20062761–3162167
   Web of Science ®Google Scholar
• ChaconMMolpeceresJBergesLGuzmanMAberturasMStability and freeze-drying of cyclosporine loaded poly (D, L lactide–glycolide) carriersEur J Pharm Sci1999829910710210732
   PubMed Web of Science ®Google Scholar
• DanhierFLecouturierNVromanBPaclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluationJ Control Release20091331111718950666
   PubMed Web of Science ®Google Scholar
• GarinotMFiévezVPourcelleVPEGylated PLGA-based nanoparticles targeting M cells for oral vaccinationJ Control Release2007120319520417586081
   PubMed Web of Science ®Google Scholar
• KimSJeongJChunKParkTTarget-specific cellular uptake of PLGA nanoparticles coated with poly (l-lysine)-poly (ethylene glycol)-folate conjugateLangmuir200521198852885716142970
   PubMed Web of Science ®Google Scholar
• Si-ShenFLiMGuofengHNanoparticles of biodegradable polymers for clinical administration of paclitaxelCurr Med Chem200411441342414965222
   PubMed Web of Science ®Google Scholar
• ChoiSKimJDesign of surface-modified poly (D, L-lactide-co-glycolide) nanoparticles for targeted drug delivery to boneJ Control Release20071221243017628158
   PubMed Web of Science ®Google Scholar
• LiYPeiYZhangXPEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in ratsJ Control Release200171220321111274752
   PubMed Web of Science ®Google Scholar
• AvgoustakisKBeletsiAPanagiZKlepetsanisPKarydasAIthakissiosDPLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood propertiesJ Control Release2002791–312313511853924
   PubMed Web of Science ®Google Scholar
• ChengJTeplyBSherifiIFormulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug deliveryBiomaterials200728586987617055572
   PubMed Web of Science ®Google Scholar
• EsmaeiliFHosseini-NasrMRad-MalekshahiMSamadiNAtyabiFDinarvandRPreparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticlesNanomedicine20073216116717468055
   PubMed Web of Science ®Google Scholar
• EsmaeiliFGhahremaniMEsmaeiliBKhoshayandMAtyabiFDinarvandRPLGA nanoparticles of different surface properties: Preparation and evaluation of their body distributionInt J Pharm20083491–224925517875373
   PubMed Web of Science ®Google Scholar
• Gomez-GaeteCTsapisNBesnardMBochotAFattalEEncapsulation of dexamethasone into biodegradable polymeric nanoparticlesInt J Pharm2007331215315917157461
   PubMed Web of Science ®Google Scholar
• DillenKVandervoortJVan den MooterGVerheydenLLudwigAFactorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticlesInt J Pharm20042751–217118715081148
   PubMed Web of Science ®Google Scholar
• PanyamJWilliamsDDashALeslie-PeleckyDLabhasetwarVSolid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticlesJ Pharm Sci20049371804181415176068
   PubMed Web of Science ®Google Scholar
• CorriganOILiXQuantifying drug release from PLGA nanoparticulatesEur J Pharm Sci2009373–447748519379812
   PubMed Web of Science ®Google Scholar
• MusumeciTVenturaCAGiannoneIPLA/PLGA nanoparticles for sustained release of docetaxelInt J Pharm20063251–217217916887303
   PubMed Web of Science ®Google Scholar
• PriorSGanderBBlarerNIn vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheresEur J Pharm Sci200215219720711849917
   PubMed Web of Science ®Google Scholar
• ZhangHCuiWBeiJWangSPreparation of poly(lactide-co-glycolide-co-caprolactone) nanoparticles and their degradation behaviour in aqueous solutionPolym Degrad Stab200691919291936
   Web of Science ®Google Scholar
• Manuela GasparMBlancoDCruzMEMJosé AlonsoMFormulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: Influence of polymer properties on enzyme loading, activity and in vitro releaseJ Control Release1998521–253629685935
   PubMed Web of Science ®Google Scholar
• MosqueiraVLegrandPGulikARelationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsulesBiomaterials200122222967297911575471
   PubMed Web of Science ®Google Scholar
• StormGBelliotSODaemenTLasicDDSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte systemAdv Drug Deliv Rev19951713148
   Web of Science ®Google Scholar
• ChoiSHParkTGG-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion methodInt J Pharm20063111–222322816423477
   PubMed Web of Science ®Google Scholar
• RosasJEHernلndezRMGasconARBiodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66Vaccine200119314445445111483270
   PubMed Web of Science ®Google Scholar
• EsmaeiliFAtyabiFPreparation of PLGA nanoparticles using TPGS in the spontaneous emulsification solvent diffusion methodJ Exp Nanosci200723183192
   Web of Science ®Google Scholar
• UtrejaPJainSTiwaryKNovel drug delivery systems for sustained and targeted delivery of anti-cancer drugs: Current status and future prospectsCurr Drug Deliv20107215216120158482
   PubMedGoogle Scholar
• ShenoyDLittleSLangerRAmijiMPoly (ethylene oxide)-modified poly (-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluationsMol Pharm20052535736616196488
   PubMed Web of Science ®Google Scholar
• MieleESpinelliGPTomaoFTomaoSAlbumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancerInt J Nanomedicine200949910519516888
   PubMed Web of Science ®Google Scholar
• GradisharWJAlbumin-bound paclitaxel: A next-generation taxaneExpert Opin Pharmacother2006781041105316722814
   PubMed Web of Science ®Google Scholar
• GreenMManikhasGOrlovSAbraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancerAnn Oncol20061781263126816740598
   PubMed Web of Science ®Google Scholar
• SoundararajanABaoAPhillipsWPerezR3rdGoinsBLiposomal doxorubicin (Doxil): In vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft modelNucl Med Biol200936551552419520292
   PubMed Web of Science ®Google Scholar
• SafraTMuggiaFJeffersSPegylated liposomal doxorubicin (Doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2Ann Oncol20001181029103311038041
   PubMed Web of Science ®Google Scholar
• LyassOUzielyBBen-YosefRCorrelation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinomaCancer20008951037104710964334
   PubMed Web of Science ®Google Scholar
• JungTKammWBreitenbachAKaiserlingEXiaoJKisselTBiodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake?Eur J Pharm Biopharm200050114716010840198
   PubMed Web of Science ®Google Scholar
• LüJMWangXMarin-MullerCCurrent advances in research and clinical applications of PLGA-based nanotechnologyExpert Rev Mol Diagn20099432534119435455
   PubMed Web of Science ®Google Scholar
• LiuXNovosadVRozhkovaEASurface functionalized biocompatible magnetic nanospheres for cancer hyperthermiaIEEE Trans Magn200743624622464
   Web of Science ®Google Scholar
• Van VlerkenLEDuanZLittleSRSeidenMVAmijiMMBiodistribution and pharmacokinetic analysis of paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer modelMol Pharm20085451652618616278
   PubMed Web of Science ®Google Scholar
• FengSSMuLChenBHPackDPolymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol®)Mater Sci Eng C2002201–28592
   Web of Science ®Google Scholar
• DongYFengSSNanoparticles of poly (D, L-lactide)/methoxy poly (ethylene glycol) poly (D, L-lactide) blends for controlled release of paclitaxelJ Biomed Mater Res A2006781121916596586
   PubMed Web of Science ®Google Scholar
• KimJHKimYSKimSHydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxelJ Control Release20061111–222823416458988
   PubMed Web of Science ®Google Scholar
• XieJWangCHSelf-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxelPharm Res200522122079209016132339
   PubMed Web of Science ®Google Scholar
• KimSYLeeYMTaxol-loaded block copolymer nanospheres composed of methoxy poly (ethylene glycol) and poly (-caprolactone) as novel anticancer drug carriersBiomaterials200122131697170411396872
   PubMed Web of Science ®Google Scholar
• ZhangZLeeSHGanCWFengSSIn vitro and in vivo investigation on PLA–TPGS nanoparticles for controlled and sustained small molecule chemotherapyPharm Res20082581925193518509603
   PubMed Web of Science ®Google Scholar
• SongCLabhasetwarVCuiXUnderwoodTLevyRJArterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog modelJ Control Release19985422012119724907
   PubMed Web of Science ®Google Scholar
• BhardwajVAnkolaDDGuptaSCSchneiderMLehrCMKumarMNVRPLGA nanoparticles stabilized with cationic surfactant: Safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in ratPharm Res200926112495250319756974
   PubMed Web of Science ®Google Scholar
• EsmaeiliFDinarvandRGhahremaniMHOstadSNEsmailyHAtyabiFCellular cytotoxicity and in-vivo biodistribution of docetaxel poly (lactide-co-glycolide) nanoparticlesAnticancer Drugs2010211435219809300
   PubMed Web of Science ®Google Scholar
• MattheolabakisGTaoufikEHaralambousSRobertsMLAvgoustakisKIn vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticlesEur J Pharm Biopharm200971219019518929649
   PubMed Web of Science ®Google Scholar
• GryparisECHatziapostolouMPapadimitriouEAvgoustakisKAnticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cellsEur J Pharm Biopharm20076711817303395
   PubMed Web of Science ®Google Scholar
• WustPHildebrandtBSreenivasaGHyperthermia in combined treatment of cancerLancet Oncol20023848749712147435
   PubMed Web of Science ®Google Scholar
• Van der ZeeJHeating the patient: A promising approach?Ann Oncol20021381173118412181239
   PubMed Web of Science ®Google Scholar
• ManchandaRFernandez-FernandezANagesettiAMcGoronAJPreparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agentsColloids Surf B Biointerfaces201075126026719775872
   PubMed Web of Science ®Google Scholar
• ShishodiaSSethiGAggarwalBBCurcumin: Getting back to the rootsAnn N Y Acad Sci20051056120621716387689
   PubMed Web of Science ®Google Scholar
• MukerjeeAVishwanathaJKFormulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapyAnticancer Res200929103867387519846921
   PubMed Web of Science ®Google Scholar
• YallapuMGuptaBJaggiMChauhanSFabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cellsJ Colloid Interface Sci20103511192920627257
   PubMed Web of Science ®Google Scholar
• GottesmanMMHow cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation award lectureCancer Res19935347477548094031
   PubMed Web of Science ®Google Scholar
• DavdaJLabhasetwarVCharacterization of nanoparticle uptake by endothelial cellsInt J Pharm20022331–2515911897410
   PubMed Web of Science ®Google Scholar
• BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Deliv Rev200254563165112204596
   PubMed Web of Science ®Google Scholar
• YanFZhangCZhengYThe effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicityNanomedicine20106117017819447200
   PubMed Web of Science ®Google Scholar
• SongXRCaiZZhengYReversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticlesEur J Pharm Sci2009373–430030519491019
   PubMed Web of Science ®Google Scholar
• Zeisser-LabouèbeMLangeNGurnyRDelieFHypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancerInt J Pharm20063261–217418116930882
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• OwensDEIIIPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
   PubMed Web of Science ®Google Scholar
• TorchilinVPTrubetskoyVSWhich polymers can make nanoparticulate drug carriers long-circulatingAdv Drug Deliv Rev1995162–3141155
   Web of Science ®Google Scholar
• TobioMSanchezAVilaAThe role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administrationColloids Surf B Biointerfaces2000183–431532310915953
   PubMed Web of Science ®Google Scholar
• StolnikSIllumLDavisSLong circulating microparticulate drug carriersAdv Drug Deliv Rev1995162–3195214
   Web of Science ®Google Scholar
• MaYZhengYLiuKNanoparticles of poly(lactide-co-glycolide)-d-a-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatmentNanoscale Res Lett2010571161116920596457
   PubMed Web of Science ®Google Scholar
• KabanovABatrakovaEAlakhovVPluronic® block copolymers as novel polymer therapeutics for drug and gene deliveryJ Control Release2002822–318921212175737
   PubMed Web of Science ®Google Scholar
• ShahNChaudhariKDantuluriPMurthyRDasSPaclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic® P85, an in vitro cell line and in vivo biodistribution studies on rat modelJ Drug Target200917753354219530913
   PubMed Web of Science ®Google Scholar
• ParveenSSahooSPolymeric nanoparticles for cancer therapyJ Drug Target200816210812318274932
   PubMed Web of Science ®Google Scholar
• ByrneJBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Deliv Rev200860151615162618840489
   PubMed Web of Science ®Google Scholar
• Brannon-PeppasLBlanchetteJNanoparticle and targeted systems for cancer therapyAdv Drug Deliv Rev200456111649165915350294
   PubMed Web of Science ®Google Scholar
• O’NealDPHirschLRHalasNJPayneJDWestJLPhoto-thermal tumor ablation in mice using near infrared-absorbing nanoparticlesCancer Lett2004209217117615159019
   PubMed Web of Science ®Google Scholar
• IshidaOMaruyamaKSasakiKIwatsuruMSize-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing miceInt J Pharm19991901495610528096
   PubMed Web of Science ®Google Scholar
• KirpotinDDrummondDShaoYAntibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsCancer Res200666136732674016818648
   PubMed Web of Science ®Google Scholar
• BondioliLCostantinoLBallestrazziAPLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acidBiomaterials201031123395340320132980
   PubMed Web of Science ®Google Scholar
• ZhengYYuBWeecharangsanWTransferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7α-APTADD to breast cancer cellsInt J Pharm2010390223424120156537
   PubMed Web of Science ®Google Scholar
• WangZChuiWKHoPCDesign of a multifunctional PLGA nanoparticulate drug delivery system: Evaluation of its physicochemical properties and anticancer activity to malignant cancer cellsPharm Res20092651162117119191012
   PubMed Web of Science ®Google Scholar
• DanhierFVromanBLecouturierNTargeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxelJ Control Release2009140216617319699245
   PubMed Web of Science ®Google Scholar
• YooHParkTFolate receptor targeted biodegradable polymeric doxorubicin micellesJ Control Release200496227328315081218
   PubMed Web of Science ®Google Scholar
• ZhangZHuey LeeSFengSSFolate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug deliveryBiomaterials200728101889189917197019
   PubMed Web of Science ®Google Scholar
• YangWChengYXuTWangXWenLTargeting cancer cells with biotin-dendrimer conjugatesEur J Med Chem200944286286818550227
   PubMed Web of Science ®Google Scholar
• Russell-JonesGMcTavishKMcEwanJRiceJNowotnikDVitamin-mediated targeting as a potential mechanism to increase drug uptake by tumoursJ Inorg Biochem200498101625163315458825
   PubMed Web of Science ®Google Scholar
• YellepeddiVKumarAPalakurthiSBiotinylated poly (amido) amine (pamam) dendrimers as carriers for drug delivery to ovarian cancer cells in vitroAnticancer Res2009298293319661298
   PubMed Web of Science ®Google Scholar
• MarekMKaiserKGruberHBiotin-pyrene conjugates with poly (ethylene glycol) spacers are convenient fluorescent probes for avidin and streptavidinBioconjug Chem1997845605669258456
   PubMed Web of Science ®Google Scholar
• CannizzaroSPaderaRLangerRA novel biotinylated degradable polymer for cell-interactive applicationsBiotechnol Bioeng199858552953510099289
   PubMed Web of Science ®Google Scholar
• MinkoTParanjpePQiuBEnhancing the anticancer efficacy of camptothecin using biotinylated poly (ethyleneglycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cellsCancer Chemother Pharmacol200250214315012172980
   PubMed Web of Science ®Google Scholar
• PatilYSadhukhaTMaLPanyamJNanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistanceJ Control Release20091361212919331851
   PubMed Web of Science ®Google Scholar
• PatilYSwaminathanSSadhukhaTMaLPanyamJThe use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistanceBiomaterials201031235836519800114
   PubMed Web of Science ®Google Scholar
• KouGGaoJWangHPreparation and characterization of paclitaxel-loaded PLGA nanoparticles coated with cationic SM5-1 single-chain antibodyJ Biochem Mol Biol200740573173917927907
   PubMedGoogle Scholar
• KocbekPObermajerNCegnarMKosJKristlJTargeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibodyJ Control Release20071201–2182617509712
   PubMed Web of Science ®Google Scholar
• AcharyaSDilnawazFSahooSKTargeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapyBiomaterials200930295737575019631377
   PubMed Web of Science ®Google Scholar
• SunBRanganathanBFengSMultifunctional poly (D, L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancerBiomaterials200829447548617953985
   PubMed Web of Science ®Google Scholar
• GaoJKouGWangHPE38 KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicityBreast Cancer Res Treat20091151294118481173
   PubMed Web of Science ®Google Scholar
• FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A2006103166315632016606824
   PubMed Web of Science ®Google Scholar
• DharSGuFXLangerRFarokhzadOCLippardSJTargeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticlesProc Natl Acad Sci U S A200810545173561736118978032
   PubMed Web of Science ®Google Scholar
• Ricci-JúniorEMarchettiJMPreparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use2006235523538
   Google Scholar
• ShahNChaudhariKDantuluriPMurthyRSRDasSPaclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic sup® P85, an in vitro cell line and in vivo biodistribution studies on rat modelJ Drug Target200917753354219530913
   PubMed Web of Science ®Google Scholar
• ChenHZhengYTianGOral delivery of DMAB-modified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapyNanoscale Res Lett20106411021711573
   PubMed Web of Science ®Google Scholar
• WinKYFengSSIn vitro and in vivo studies on vitamin E TPGS-emulsified poly (D, L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulationBiomaterials200627102285229116313953
   PubMed Web of Science ®Google Scholar
• DongYFengSPoly (D, L-lactide-co-glycolide)(PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapyInt J Pharm20073421–220821417560058
   PubMed Web of Science ®Google Scholar
• HeXMaJMercadoAEXuWJabbariECytotoxicity of paclitaxel in biodegradable self-assembled core-shell poly (lactide-co-glycolide ethylene oxide fumarate) nanoparticlesPharm Res20082571552156218196205
   PubMed Web of Science ®Google Scholar